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Three beta-hydroxysteroid dehydroge!lase/ [..5-[..4 isomer-
ase (3,B-HSD) catalyses an obligatory step in the biosynthesis 
of all classes of hormonal steroids, namely, the oxidation/ 
isomerization of 3,B-hydroxy-5-ene steroids into the corre-
sponding 3-keto-4-ene steroids in gonadal as well as in pe-
ripheral tissues. Because humans are unique with some 
primates in having adrenals that secrete large amounts of the 
steroid precursors dehydroepiandrosterone (DHEA) and its 
sulfate (DHEA-S) and its exceptionally large volume makes 
the skin an important site of steroid biosynthesis, we have 
isolated and characterized eDNA clones encoding 3,B-hy-
droxysteroid dehydrogenase/ [..5-[..4 isomerase from a 
human skin Agt11 library. The longest clone obtained con-
tains the entire coding sequence for type I 3,B-HSD (372 
amino acids) as well as an additional 131 nucleotides in the 
5' -untranslated region. The insert of 1647 bp containing the 
B ecause the skin is rich in steroidogenic enzymes and is the largest organ in the human body, this tissue must be considered as an important site of sex steroid forma-tion. In fact, the skin possesses all the enzymes required for the transformation of the steroid precursors of adre-
nal origin, namely, dehydroepiandrosterone (DHEA) and especially 
its sulfate, DHEA-S, into active androgens and estrogens [1- 6]. 
The first step in the conversion of DliEA and androst-5-ene-
3p, 17 P-diol (L15-diol) into 4-androstenedioJ1e and testosterone, re-
spectively, is catalyzed by 3p-hydroxystero id dehydrogenase/ L15-
~4 isomerase, hereafter called 3p-HSD. Because the same enzyme 
also transforms C-21 steroids into the corresponding 4-ketoste-
roids, 3P-HSD is expressed, not only in classical steroidogenic tis-
sues (adrenals, testes, ovaries, and placenta) but also in a large series 
of peripheral intracrine tissues [3,5,7]. In fact, 3P-HSD catalyzes an 
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entire coding region has been inserted in a pCMV expression 
vector and transfected into human cervical carcinoma cells 
(HeLa). The expressed enzyme efficiently catalyzes the 
transformation of pregnenolone, DHEA, and dihydrotestos-
terone into progesterone, 4-androstenedione, and 5a-an-
drostane-3,B, 17 ,B-diol, respectively. Using the enzyme ex-
pressed in HeLa cells, we have shown cyproterone acetate, a 
progestin used in the treatment of acne and hirsutism, as well 
as norgestrel and norethindrone, two steroids widely used as 
oral contraceptives, to be relatively potent inhibitors, with Ki 
values of 0.38 ,uM, 1.3,uM, and 1.2,uM, respectively. Im-
munohistochemical localization of 3,B-HSD, illustrated by 
using an antibody raised against human placental 3,B-HSD, 
shows that the enzyme is localized in sebaceous glands. ] 
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essential step in the biosynthesis of all steroids, namely, progester-
one, mineralocorticoids, glucocorticoids, androgens, and estrogens. 
Following purification of 3P-HSD from human placenta and de-
velopment of antibodies against the enzyme in rabbits [8,9], we have 
isolated and characterized a first cDNA species [6] and gene [7]. 
Recently, we have isolated a second 3P-HSD cDNA species that is 
the almost exclusive species expressed in the adrenals and gonads 
and was chronologically designated as human type II 3P-HSD [4] . 
We have recently characterized the structure of the corresponding 
human type II 3P-HSD gene [10]. In the rat, three types of3P-HSD 
cDNA [11,12] have so far been characterized, and one bovine [13] 
and one macaque [14] eDNA clone have been described. 
In addition to the well-recognized importance of steroids in nor-
mal skin physiology as well as in pathologic states, it is also quite 
possible that steroids synthesized in the skin have some generalized 
effects in other organs and tissues. Considering the essential role of 
3P-HSD in the biosynthesis of all steroids in the skin from the 
adrenal precursors DHEA-S and DHEA, we have cloned cDNA 
encoding 3P-HSD from a human skin eDNA library, inserted the 
cDNA in an expression vector, and expressed the functional eDNA 
in HeLa cells. Immunohistochemical localization of 3P-HSD in 
human skin has also been performed by using an antiserum raised 
against the purified human placental enzyme. 
MATERIALS AND METHODS 
Materials All restriction enzymes and T4 DNA ligase were ob-
tained from Pharmacia Inc. (Canada) , whereas [14C]DHEA and 
(14C]androstenedione were from Dupont Inc. (Canada) HeLa cells 
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were obtained from the American Type Culture Collection (Rock-
ville, MD) . Cyproterone acetate was obtained from Schering AG, 
Germany, whereas Epostane was provided by Sterling-Winthrop 
Research Institute, Rensslaer, New York and 4-MA was from 
Merck Sharp & Dohme Research Laboratories, Rahway, NJ. 
Cloning and Sequence Determination A human skin Agt11 
cDNA library obtained from Clontech Laboratories Inc. (Palo Alto, 
CAl, was screened with human placental 3P-HSD cDNA (hp3P-
HSD63) [6) labelcd with (a-32P)dCTP by the random primer 
method [15J as described [7J . Positive recombinant plaques were 
purified by replating twice and grown in liquid culture. Phages 
were isolated by centrifugation for 1.5 h at 105,000 X g and DNA 
was isolated by phenol extraction. EcoRI restriction fragments ob-
tained from phage DNA were subcloned into Bluescript SK vector 
(Stratagene, San Diego, CAl and plasmid DNA was prepared by 
alkaline lysis [16). Sequencing of double-stranded plasmid DNA 
was performed according to the dideoxy chain termination method 
[17) using modified T7 DNA polymerase [18) (Sequenase Kit, 
Unitcd States Biochemical Corp., Cleveland, Ohio) . Oligonucleo-
tide primers were synthetized in our laboratory with a Biosearch 
DNA synthetizer. 
ACTCTTCTGTCC -1 20 
hp 
hsk AGCTTTTAACAATCTAACTAATGCCCTCTCCAGGGTCACCCTAGGGTCACCCTAGAATCAGATCTGCTCCCCAGCATCTTCTGTTTCCTGGTGAGTGATTCCTGCTACTTTGGATGGCC -1 
hp 
hsk ATG ACG GGC TGG AGC TGC CTT GTG ACA GGA GCA GGA GGG TTT CTG GGA CAG AGG ATC ATC CGC CTC TTG GTG AAG GAG AAG GAG CTG AAG 90 
Met Thr Gly Trp Ser Cys Leu Val Thr Gly Ala Gly Gly Phe Leu Gly Gln Arg lle lle Arg Leu Leu Val Lys Glu Lys Glu Leu Lys 
10 20 30 
hp 
hsk GAG ATC AGG GTC TTG GAC AAG GCC TTC GGA CCA GAA TTG AGA GAG GAA TTT TCT AAA CTC CAG AAC AAG ACC AAG CTG ACA GTG CTG GAA 180 
Glu lle Arg Val Leu Asp Lys Ala Phe Gly Pro Glu Leu Arg Glu Glu Phe Ser Lys Leu Gln Asn Lys Thr Lys Leu Thr Val Leu Glu 
40 50 60 
hp 
hsk GGA GAC ATT CTG GAT GAG CCA TTC CTG AAG AGA GCC TGC CAG GAC GTC TCG GTC ATC ATC CAC ACC GCC TGT ATC ATT GAT GTC TTC GGT 270 
Gly Asp lle Leu Asp Glu Pro Phe Leu Ly s Arg Ala Cys Gln Asp Val Ser Va l lle lle His Th~ Ala Cys lle lle Asp Val Phe Gly 
70 80 90 
hp 
hsk GTC ACT CAC AGA GAG TCT ATC ATG AAT GTC AAT GTG AAA GGT ACC CAG CTC CTG TTA GAG GCC TGT GTC CAA GCT AGT GTG CCA GTC TTC J60 
Val Thr His Arg Glu Ser lle Met As n Val Asn Val Lys Gly Thr Gln Leu Leu Leu Glu Ala Cys Val Gln Ala Ser Val Pro Val Phe 
100 110 120 
hp 
hsk ATC TAC ACC AGT AGC ATA GAG GTA GCC GGG CCC AAC TCC TAC AAG GAA ATC ATC CAG AAT GGC CAT GAA GAA GAG CCT CTG GAA AAC ACA 450 
lle Tyr Thr Ser Ser lle Glu Val Ala Gly Pro Asn Ser Tyr Lys Glu lle lle Gln As n Gly Hi s Glu Glu Glu Pro Leu Glu Asn Thr 
130 140 1 50 
hp 
hsk TGG CCC GCT CCA TAC CCA CAC AGC AAA AAG CTT GCT GAG AAG GCT GTA CTG GCG GCT AAC GGG TGG AAT CTG AAA AAC GGC GGC ACC CTG 540 
Trp Pro Ala Pro Tyr Pro His Ser Lys Lys Leu Ala Glu Lys Ala Val Leu Ala Ala Asn Gly Trp Asn Leu Lys Asn Gly Gly Thr Leu 
160 170 180 
hp 
hsk TAC ACT TGT GCC TTA CGA CCC ATG TAT ATC TAT GGG GAA GGA AGC CGA TTC CTT TCT GCT AGT ATA AAC GAG GCC CTG AAC AAC AAT GGG 6JO 
Tyr Thr Cys Ala Leu Arg Pro Met Tyr lle Tyr Gly Glu Gly Ser Arg Phe Leu Ser Ala Ser lle Asn Gl u Al a Leu Asn Asn Asn Gly 
190 200 210 
hp 
hsk ATC CTG TCA AGT GTT GGA AAG TTC TCC ACT GTT AAC CCA GTC TAT GTT GGC AAT GTG GCC TGG GCC CAC ATT CTG GCC TTG AGG GCC CTG 720 
lle Leu Ser Ser Val Gly Lys Phe Ser Thr Val Asn Pro Val Tyr Val Gly Asn Val Ala Trp Ala Hi s lle Leu Ala Leu Arg Ala Leu 
220 2JO 240 
hp 
hsk CAG GAC CCC AAG AAG GCC CCA AGC ATC CGA GGA CAG TTC TAC TAT ATC TCA GAT GAC ACG CCT CAC CAA AGC TAT GAT AAC CTT AAT TAC 810 
Gln Asp Pro Ly s Lys Ala Pre Ser lle Arg Gly Gln Phe Tyr Tyr lle Ser Asp Asp Thr Pro Hi S Gln Se r Tyr Asp Asn Leu Asn Tyr 
250 260 270 
hp 
hsk ACC CTG AGC AAA GAG TTC GGC CTC CGC CTT GAT TCC AGA TGG AGC TTT CCT TTA TCC CTG ATG TAT TGG ATT GGC TTC CTG CTG GAA ATA 900 
Thr Leu Ser Lys Glu Phe Gly Leu Arg Leu Asp Ser Arg Trp Ser Phe Pro Leu Ser Leu Met Tyr Trp lle Gly Phe Leu Leu Glu lle 
280 290 JOO 
hp 
hsk GTG AGC TTC CTA CTC AGG CCA ATT TAC ACC TAT CGA CCG CCC TTC AAC CGC CAC ATA GTC ACA TTG TCA AAT AGC GTA TTC ACC TTC TCT 990 
Val Ser Phe Leu Leu Arg Pro lle Tyr Thr Tyr Arg Pro Pro Phe As n Arg Hi s lle Val Thr leU Ser As n Ser Val Phe Thr Phe Se r 
310 J20 JJO 
Leu 
~ ~-
hsk TAT AAG AAG GCT CAG CGA GAT CTC GCG TAT AAG CCA CTC TAC AGC TGG GAG GAA GCC AAG CAG AAA ACG GTG GAG TGG GTT GGT TCC CTT 1080 
Tyr Lys Lys Ala Gln Arg Asp Leu Ala Tyr Lys Pro Leu Tyr Ser Trp Glu Glu Ala Lys Gln LyS Thr Val Glu Trp Val Gly Ser Leu 
J40 J50 J60 
Asn 
-A-hp 
hs k GTG GAC CGG CAC AAG GAG ACC CTG AAG TCC AAG ACT CAG 
Val Asp Arg His Lys Glu Thr Leu Lys Ser Lys Thr Gln 
J70 
TGA TTTAAGGATGACAGAGATGTGCATGTGGGTATTGTTAGGAGATGTCATCAAGCTCCACCCTCC 118 5 
End 
hp ----------------------- _______________________________________________________________ ------- _________________________ _ 
hsk TGGCCTCATACAGAAAGTGACAAGGGCACAAGCTCAGGTCCTGCTGCCTCCCTTTCATACAATGGCCAACTTATTGTATTCCTCATGTCATCAAAACCTGCGCAGTCATTGGCCCAACA 1J04 
hp ------------------------- _________________ __ __ ________________ ____ _________________ _ __ ------ __________________________ _ 
hsk AGAAGGTTTCTGTCCTAATCATATACCAGAGGAAAGACCATGTGGTTTGCTGTTACCAAATCTCAGTAGCTGATTCTGAACAATTTAGGGACTCTTTTAACTTGAGGGTCGTTTTGACT 142J 
hp ------------------------___ ______________ ___ _______ ______________ __ ___________________ -----------_____________ _ 
hsk ACTAGAGCTCCATTTCTACTCTTAAATGAGAAAGGATTTCCTTTCTTTTTAATCTTCCATTCCTTCACATAGTTTGATAAAAAGATCAATAAATGTTTGAATGTTAAAAAA 15J4 
Figure 1. Comparison of the nucleotide sequences of human skin (hsk 3P-HSD17) (present data) and human placental (hp 3P-HSD63) eDNA. One-hundred 
thirty-one additional nucleotides are present in the 5' untranslated region of skin eDNA. The two nucleotide changes at amino acid positions 338 and 367 are 
indicated with the corresponding amino acids. 
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Construction of Expression Vector and Transient Expression 
iu Mammalian HeLa Cells A EcoRI-EcoRI fragment of human 
skin 3P-HSD (hsk3P-HSD) cDNA containing the entire coding 
region, the 3' -untranslated region and 131 nucleotides in the 5'-
noncoding region was inserted downstream to the cytomegalovirus 
(CMV) promoter in the pCMV vector (kindly provided by Dr. 
Michael B. Mathews, Cold Spring Harbor Laboratories, NY). This 
construction was sequenced in both orientations and amplified in 
Escherichia coli DH5a competent cells. Recombinant plasmids 
(pCMV-hsk3PHSD) were prepared by the alkaline-lysis procedure 
[16] and purified by two cesium chloride-ethidium bromide den-
sity-gradient centrifugations. Fifteen micrograms of vector were 
used to trans feet human cervical carcinoma cells (He La) using the 
calcium-phosphate procedure [4,19]. Cells were plated initially at 
104 cells/cm2 in 75-cm2 Falcon culture flasks and grown in Dul-
becco's modified Eagle's medium containing 10% (v Iv) fetal bovine 
serum supplemented with 2 mM L-glutamine, 1 mM sodium pyru-
vate, 100 IU penicillin/ml, and 100)1g streptomycin sulfate/ml. 
Mock transfections were carried out with pCMV alone and the 
transfection efficiency was monitored by co-transfection of the 
pCMV-Hsk3P-HSD vector with the pXGH5 plasmid [20]. The 
media were collected 24 h after transfection for the assay of GH 
secretion by RIA; cel ls were harvested by scraping with a rubber 
policeman and suspended in 0.5 ml of buffer containing 50 mM 
potassium phosphate (pH 7.4), 20% glycerol, and 1 mM EDTA for 
enzymatic assay. 
Enzymatic 3P-HSD Assay Transfected cells were incubated at 
37"C in 0.5 ml of 50 mM sodium phosphate buffer (pH 7.4) con-
taining 20% glycerol, 1 mM EDTA, and 1 mM NAD+ for 1 h in 
the presence of the indicated concentrations of radio labeled steroid 
substrate. The assay was performed essentially as described [7,8]. 
Immediately after incubation, steroids were extracted twice from 
the incubation medium with 2 ml of methylene chloride and the 
organic phase was evaporated to dryness. The steroids were then 
separated by thin-layer chromatography on silica gel in the ben-
Zene-acetone (4: 1; v: v) system. Substrate and metabolite(s) were 
identified by comparison on each TLC plate with reference steroids 
and revealed by autoradiography. Radioactivity was measured by 
liquid scintillation spectrometry. 
Immunoblot Analysis Immunoblotting was performed as de-
scribed [6] . Briefly, cells were Iyzed and electrophoresed on a 5-
15% sodium dodecyl sulfate polyacrylamide gel [21]. The gel was 
then transferred to nitrocellulose filters for 4 h at 60 V. Blots were 
treated three times for 30 min with 5% fat-free milk in phosphate-
buffered saline (PBS) containing 0.1 % Nonidet P-40. Antiserum 
against 3P-HSD was added at dilution 1 : 2000 and incubated at4 °C 
for 18 h. Blots were then washed three times with PBS containing 
5% fat-free milk and 0.1 % NP-40. After washing, (125I]-labeled 
goat antirabbit immunoglobulin was added at dilution 1 : 2000 and 
incubated for 4 h at 4 ° C. After three washes with the same buffer, 
blots were exposed to Kodak XAR-5 films overnight at -80°C 
with intensifying screens. 
Immunohistochemistry Human skin from the mid-abdominal 
region was fixed by immersion in Bouin's solution for 3 d, dehy-
drated in ethanol, and embedded in paraffin. Six-micron sections 
Were then cut and mounted onto glass slides. The sections were 
incubated overnight at 4°C with 3P-HSD antiserum [6,9] diluted 
1: 500 in Tris-saline buffer (pH 7.6). The slides were then washed 
I!1 the same buffer and incubated at room temperature for 4 h with 
peroxidase-labeled goat anti-rabbit y-globulins (Hyclone, Logan, 
Dtah) diluted 1: 500. The peroxidase activity was revealed follow-
ing a 5-min incubation at room temperature in a medium contain-
ing 0.05% diaminobenzidine and 0.01 % H 20 2. The sections were 
Ilot counterstained. 
IUbonuclease Protection Assay Regions corresponding to nu-
cleo tides 688 - 907 for the human type I 3P-HSD and to nucleotides 
685-904 for the human type II 3P-HSD were obtained by amplifi-
cation using the polymerase chain reaction (PCR). The 220-bp 
HUMAN SKIN 3P-HSD 417 
fragments were subcloned in the Bluescript KS vector and se-
quenced in both directions. The recombinant plasmids were linear-
ized with Not I and transcribed with [a_32P] UTP (800 Ci/mmol) 
(Amersham) to generate type I and type II specific cRNA probes of 
315 nucleotides using T3 RNA [32P]labeled polymerase of the 
transprobe T kit (Pharmacia LKB Biotechnology). Three to twenty 
micrograms of human total or poly(A)+ mRNA were hybridized 
with 8 X 104 cpm, type I or type II cRNA probe at 35 °C for 14 h. 
Thereafter, RNA samples were diluted tenfold with 10 mM Tris-
HCI (pH 7.5), 300 mM NaCl, and 5 mM EDTA in the presence of 
40 mg/ml RNase-A and 250 U/ml RNase-Tl and incubated at 
37°C for 1 h. Samples were then treated with a final concentration 
of 0.2 mg/ml proteinase-K and 0.5% sodium dodecyl sulfate for 
15 min at 37°C, extracted, and purified as previously described 
[8,11]' RNase-resistant hybrids were analyzed by electrophoresis in 
a denaturating polyacrylamide urea sequencing gel. Autoradiogra-
phy was performed at 80°C with two intensifying screens. 
RESULTS 
Isolation and Characterization of 3P-HSD cDNA Clone 
from Human Skin A human skin cDNA library constructed in 
Agtl1 was screened by using human placental3p-HSD eDNA clone 
3P-HSD63 as probe [6]. Five primary clones were isolated from 
about 400,000 plaques and their nucleotide sequence was deter-
mined [17] . The longest clone contains an open reading frame en-
coding 372 amino acids. The nucleotide sequence of the coding 
region of this cDNA is identical to that of human placental3p-HSD 
previously reported [6] except for the substitution of two nucleo-
tides, namely, the replacement of A by C at residue 367 (Fig 1) 
changing Asn to Thr, whereas the replacement of C by T at residue 
338 conserves the Leu residue but deletes a BglII restriction site. 
These two changes have also been observed in the 3P-HSD gene [7] 
and have been attributed to polymorphism [22]. When compared 
with the human placental 3P-HSD cDNA previously reported [6], 
A 
B 
~4-
DHEA-
KDa 
42 -
CONTROL TRANSF 
p T c 
Figure 2. Expression of eDNA encoding human skin 3P-HSD in HeLa 
cells. (A) Autoradiograph of thin-layer chromatography of the transforma-
tion of 1 ,uM [14c]DHEA by control mock-transfected cells (CONTROL) 
and cells transfected with the pCMV-hsk3,BHSD expression vector. (B) 
Immunoblot analysis of HeLa transfected cells. Lalle P, purified human 
placental 3P-HSD; ialle T, cells transfected with the pCMV-hsk3,BHSD 
vector; ialle C, mock-transfected cells. 
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Figure 3. Ribonuclease protection analysis of the distribution of human 
types I and II 3ft-HSD mRNA in the human skin adrenal and placenta. 
Samples of total RNA from the human adrenal (10 Jig) (A), placenta (20 Jig) 
(P) , skin (20 I1g) (S), and yeast tRNA as control (20 I1g) (C) were hybridized 
as described in Materials and Methods with either probe (315 nucleotides). The 
longest protected fragment (220 nucleotides) corresponds to the homolo-
gous RNA species protected by the cRNA probe. Protected fragments of98 
and 64 nucleotides correspond to predicted well recognized mismatches for 
RNase A. Lalles corresponding to the adrena l and placenta were exposed to 
X-Ray film for 9 h, whereas those from skin and control were exposed for 
9 d. 
the present clone obtained from human skin contains an additional 
131 nucleotides in the 5' untranslated region (Fig 1), 35 of these 
nucleotides belonging to the first untranslated exon of the type I 
3P-HSD gene [8]. 
Expression of Human Skin 3P-HSD in HeLa Cells As illus-
trated in Fig 2A, HeLa cells transfected with pCMV-hsk3PHSD 
catalyze efficiently the transformation ofDHEA into androstenedi-
one, whereas in mock-transfected cells, no enzymatic activity can be 
detected. As illustrated in Fig 2B, the 3P-HSD activity described 
above corresponds to the expression of a newly produced protein 
that migrates at the same position as purified human placental 3P-
HSD, as revealed by immunoblot analysis using the antiserum raised 
against purified human placental 3p-HSD. 
In order to determine with precision the relative level of expres-
sion of the type I and type II 3P-HSD genes in human skin or the 
relative abundance of the two corresponding types of 3P-HSD 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Table I. Kinetic Constants for Human Skin 3P-HSD Activity 
Transfected in HeLa Cells 
Vmax' Relative Specificity 
(nmole/min/mg (Vmax/Km) 
Substrate Km·{!J.M) protein) (ml/min/mg) 
DHEA 0.13 0.93 7.15 
Pregnenolone 0.33 2.43 7.23 
DHT 2.1 14.12 6.72 
, K.m and Vmax values were determined by Lineweaver-Burk plot analysis. Incubation 
reactions were performed in duplicate as described in Materials a"d Methods with sub-
strate concentrations of 0.005 , 0.01,0.025,0.050,0.1,0.25,0.5, 1,2.5,5, and 10 JIM. 
NADH (1 mM) was used when DHT was the substrate. 
mRNA, a ribonuclease assay was performed. This highly sensitive 
assay permits the discrimination of a few base-pair mismatches that 
occur after annealing type I and type II 3P-HSD mRNA probes ~o 
the mRNA species extracted from human skin. As can be seen in Fig 
3, type I 3P-HSD mRNA is the exclusive mRNA species detectable 
in the skin and placenta, whereas in the adrenal, type II 3P-HSD 
mRNA was the only RNA species detected. These conclusions are 
clearly supported by the presence of the expected full-length pr~­
tected fragment (220 nucleotides) when the type I cDNA probe IS 
used with skin and placental RNA as well as the occurrence of the 
expected small fragments of 98 and 64 nucleotides when the type II 
cRNA probe was used. The opposite pattern was found when adre-
nal mRNA was studied, thus indicating the exclusive presence. of 
type II 3P-HSD mRNA in the human adrenal. In agreement ~Ith 
our previous data [4], even with longer exposure, it was not pOSSible 
to detect type I 3P-HSD in human adrenal mRNA. . 
The homogenate of transfected cells was then used to determme 
the affinity constant (Km) towards DHEA (C-19 steroid), Preg 
(C-21 steroid), and DHT (saturated steroid). As indicated in Table!, 
comparable relative specificities (Vmax/km) values of 7.15, 7.23, 
and 6.72 ml.mg/min were measured for pregnenolone, DHEA, and 
dihydrotestosterone (DHT) transformation, respectively. HoW-
ever, the Vmax calculated for DHT (14.12 nmoles/min/mg pro-
tein) is much higher than that of the unsaturated substrates DHEA/ 
(0.95 nmoles/min/mg protein) and pregnenolone (2.4 nmoles
d min/mg protein), whereas the Km was higher at 2.1 pM compare 
with 0.13 pM and 0.33 pM for DHEA and pregnenolone, respec-
tively. . 
In order to obtain more information about the properties of ~he 
enzyme and the inhibition of its activity by steroids, we next studied. 
the effect of cyproterone acetate, a steroid derivative used for the 
treatment of hirsutism [23]' and norgestrel and norethindrone, rwO 
progestins widely used as contraceptives [24], as well as a Sa-reduc-
tase inhibitor, 4-MA [25] and a known inhibitor of 3P-HSD, Epos-
tane [26]' on the activity of expressed human skin 3p-HSD. Dlxof plot analysis using two concentrations (0 .25 pM and 0.5 pM) °d 
DHEA as substrate shows Ki values of 0.12, 0.16, 0.38, 1.2, an 
1.3 pM, respectively, for 4-MA, Epostane, cyproterone acetate, 
norethindrone, and norgestrel (Table II). . . 
As illustrated in Fig 4, a high level of3P-HSD immunoreactiVity 
is seen in the sebaceous glands as well as sebaceous gland ducts, 
Table n. Inhibition Constants of Steroid Derivatives on 
Human Skin 3P-HSD Transfected in HeLa Cells' 
_______________ S_te_ro_id ______________ K_I~{!J._M~) ____ ------
4-MA 0.12 
Epostane 0.16 
Cyproterone acetate 0.38 
Norethindrone 1.20 
____________ N_o_r~g~e_st_re_I ___________________ 1_.3_0 ________ -----
'Inhibition experiments were performed at two fixed concentrations of D!{EA 
(0.25 JIM and 0.5 JIM). K.i "alues were calculated by Dixon plot analysis. 
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Figure 4. Immunohistochemical localization of3P-HSO in human skin. Immunostaining for 3P-HSO can be seen in the cytoplasm of sebaceous gland (SG) 
and sebaceous duct (SO) cells. Magnification X 200. 
whereas the surrounding tissue shows no significant immunoreac-
tivity. 
DISCUSSION 
The present data show that the exclusive detectable 3P-HSD gene 
expressed in human skin is type I with a coding sequence identical to 
the gene exclusively expressed in the placenta [7]. When compared 
to the cDNA previously isolated from human placenta [7J, the 
cDNA obtained from a human skin library contains, however, an 
additional 131 nucleotides in the S'-noncoding region, thus coding 
almost entirely the 5'-noncoding region, which contains 138 nu-
cleotides. 
The present data show that the Vmax of3P-HSD activity is much 
higher when DHT is used as substrate compared to the values mea-
sured with pregnenolone and DHEA. This observation could be 
related to the fact that the transformation ofDHT requires only the 
dehydrogenase activity, whereas transformation of DHEA and 
pregnenolone requires both dehydrogenase and isomerase activities. 
In fact, these two activities have been demonstrated to reside at two 
distinct sites within the single 3P-HSD protein [27]. Km values for 
DHEA and pregnenolone obtained with HeLa transfected cells 
Were similar to the data obtained from HeLa cells transfected with 
rat type I 3fJ-HSD [11]. 
Steroidogenic enzymes are well known to be present in human 
skin. In fact, human skin has been shown to convert DHEA into 
64-dione [28 ,29], which is then converted into testosterone [30-
32]. In addition, Sa-androstane-3fJ,17 P-diol was a major metabolite 
when skin from back or scalp was incubated with [3H] testosterone 
[33] and i14-dione was found when skin was incubated with hair 
roots [34,35]. The physiologic importance of3fJ-HSD in the human 
skin is clearly supported by the previous observation that D HEA can 
. stimulate sebaceous gland secretion in humans [2,36]. 
At puberty, the increase in the secretion ofDHEA, especially the 
secretion of its sulfated form, DHEA-S [37] , is associated with an 
increase in sebaceous gland size and sebum ~roduction [38,39], 
Which frequently leads to problems of acne [40,41]. In fact, an 
elevation in skin 3P-HSD [42] and Sa-reductase [43,44] activities 
has been described in hirsutism and acne. Because sebaceous gland 
size has been found to be increased in hirsutism and acne [45,46] and 
3fJ-HSD (present data) is apparently mainly localized in sebaceous 
glands in the human, the observed elevation in 3P-HSD and andro-
gen formation in the skin of such patients [42] could be a cause or an 
effect of increased sebaceous gland volume as well as being involved 
in the characteristics of lipid secretion by the sebaceous glands. It 
should also be mentioned that the metabolism of DHEA has been 
found to be higher in the skin of hirsute compared to normal 
women [42]. 
The present observation of the immunocytochemical localization 
of 3P-HSD in sebaceous glands in the human skin is in agreement 
with data obtained by histochemistry [1,47,48]. The localization of 
3fJ-HSD in sebaceous glands is also supported by the distribution of 
enzymatic activity in different body sites of human skin during 
embryonic development [49] and in developed skin [32]. Microdis-
sected sebaceous glands have also been shown to possess 3P-HSD 
activity [32]' 
It should be mentioned that more than 90% of 3P-HSD activity 
in forehead skin was localized in isolated sebaceous glands, although 
some activity was also found in hair follicles, epidermis, and eccrine 
glands [32]. Three 3P-HSD activity was also found in the sebaceous 
glands from men with alopecia [50]. On the other hand, in axillary 
skin, most 3P-HSD was localized in sweat glands (both eccrine and 
apocrine sweat glands are present in large numbers in axillary skin) . 
The apocrine glands, like sebaceous glands, develop from the hair 
follicle and form a much larger volume than sebaceous glands in the 
pubic and axillary regions. Another argument supporting the role of 
3P-HSD in sebaceous gland activity is the finding that androst-5-
ene-3p,17 P-diol (i1S-diol) is a potent stimulator of sebum secretion 
in the rat [51] . It should be mentioned that the conversion ofDHEA 
into i14-steroids has also been observed in axillary apocrine glands 
[32] and in plucked hair follicles [51- 53]. 
Both DHEA and i1S-diol require the action of3P-HSD as the first 
step of enzymatic catalysis to form i14-dione and testosterone, re-
spectively. i14-dione is then converted into testosterone by the ac-
tion of 17 p-hydroxysteroid dehydrogenase, whereas Sa-reductase 
further transforms testosterone into DHT. The presence of 3fJ-
HSD, 17P-HSD, and Sa-reductase in the sebaceous glands may 
allow the sebaceous glands to develop fully in both boys and girls in 
utero and at puberty at the time of increased DHEA and DHEA-S 
formation by the adrenals [54]. Three fJ-HSD is thus likely to playa 
major role during intrauterine life when the sebaceous glands de-
velop to a state of maturity in both male and female fetuses, the 
androgens probably originating from the conversion ofDHEA and 
DHEA-S by 3fJ-HSD [54]. 
In analogy with our recent studies that showed a close correlation 
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between the levels of3jJ-HSD mRNA, protein, and enzymatic activ-
ity as well as steroid production in bovine ovaries during the estrus 
cycle [55) as well as in rat testis [5 6) and ovary [57) upon stimulation 
by hCG, changes in the level of 3jJ-HSD expression and activity 
could playa major role in androgen formation in sebaceous glands, 
thus controlling sebum secretion. This suggestion is well supported 
by the finding of a close correlation between 3jJ-HSD activity and in 
vivo sebum excretion rate in humans [58) . 
Although the steroids produced in various components of the 
skin are likely to have some systemic effects, it is most probable that 
the steroids synthesized in the skin from adrenal precursors exert 
major intracrine effects in the same cells where they are produced 
[3). These steroids could also exert autocrine 9r paracrine effects on 
neighboring cells. The availability of cDNA encoding the main 
steroidogenic enzymes expressed in the skin offers important tools 
for a detailed analysis of the endocrine and other factors regulating 
steroid biosynthesis and action in the skin. Receptors for androgens, 
estrogens, and glucocorticoids are present in human skin [59,60) 
and steroids are known to exert major effects on skin physiology and 
pathology. 
We would like to thank Drs. M. Mathews and G. Moris for providitlg the pCMV 
vector. 
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